XORTX Therapeutics (XRTX) provided an update regarding communications with the US Food and Drug Administration. At the request of the FDA a ...
is pleased to announce that it completed its pre-submission meeting with the U.S. Food and Drug Administration ("FDA") as scheduled on March 20, 2025. The purpose of the meeting was to discuss ...
The purpose of the meeting was to reach agreement with the FDA on the proposed content and format of the Company’s planned sNDA submission including the clinical and nonclinical requirements.
The Food and Drug Administration (FDA) abruptly canceled a vaccine advisory meeting where members were slated to discuss influenza vaccine strains. The meeting was scheduled for March 13.
The purpose of this meeting will be to review the XRx-026 program and its readiness for submission of a New Drug Application ...
The Senate voted Tuesday to confirm the heads of two major federal health agencies. Jay Bhattacharya, MD, PhD, will become ...
Why was this meeting canceled? It's an important meeting. What's the plan for flu vaccines this year," Paul Offit, a member of the FDA advisory committee and director of the Vaccine Education ...
Why was this meeting canceled? It's an important meeting. What's the plan for flu vaccines this year," Dr. Paul Offit, a member of the FDA advisory committee and director of the Vaccine Education ...
The statement confirms a report by Reuters that the Vaccine and Related Biological Products Advisory Committee meeting, scheduled for March 13, has been canceled. An FDA spokesperson said the ...
"A planned March 13 meeting of the FDA’s Vaccines and Related Biological Products Advisory Committee on the influenza vaccine strains for the 2025-2026 influenza season in the northern ...
The timing of the meeting is crucial because flu vaccine production is a lengthy process, with some doses still made using chicken eggs. Each year, FDA advisers meet to formally decide which flu ...
What’s the plan?” he said. The FDA confirmed the cancellation in a statement sent to CNN on Thursday. “A planned March 13 meeting of the FDA’s Vaccines and Related Biological Products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results